Prevada Medical
PrivateLast Round
Accelerator
Jul 12, 2022
Company Overview
Prevada Medical is a medical technology company that develops disposable mouthpiece solutions designed to reduce the risk of ventilator-associated pneumonia in intensive care units.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Prevada Medical Comparables
Compare Prevada Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeVap, Inc. | 78% | |
| ReddyPort | 73% | |
| Medtronic | 73% | |
Prevada Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jul 12, 2022 | ||||
| Grant | May 19, 2022 |
Prevada Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Charles Stewart Mott Foundation | Accelerator |
| XLerateHealth | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2022
Received funding from Americas Seed Fund SBIR/STTR Programs.
Prevada Medical Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Prevada Medical's valuation, stock price, and market status.